Inno-Gene SA operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Inno-Gene SA with three other
miscellaneous service companies in Europe:
Kuros Biosciences AG
sales of 1.06 million Swiss Francs [US$1.09 million]
PCI Biotech Holding ASA
(10.48 million Norwegian Kroner [US$1.25 million]
Faron Pharmaceuticals Oy
based in the United Kingdom
(£946,543.82 [US$1.23 million]
During the year ended December of 2016, sales at
Inno-Gene SA were 4.63 million Polish New Zlotys (US$1.24 million).
increase of 10.5%
versus 2015, when the company's sales were 4.19 million Polish New Zlotys.
This was the fifth consecutive year of sales increases at Inno-Gene SA
(and since 2011, sales have increased a total of 140%).